September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease. This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for projects aimed at eliminating advanced disease from affected men. Co-lead by Drs. Paul Rennie, Art Cherkasov & Emma Tomlinson-Guns, the project "Pre-clinical development of the next-generation anti-androgens for the treatment of drug-resistant and advanced prostate cancer" is one of only two grants awarded. The three-year grant is for $1,463,090 starting on October 1, 2014.Click here to read the Prostate Cancer Canada press release.